Anglo French Drugs- 2022-2023 Annual Report - Exceptional Profit of Rs. 291 cr- Please Recheck This

 For 2022-2023  Annual Report please click ;-

https://www.msei.in/SX-Content/Listing/Annual-Reports/2023/AFDIL-2023.pdf

Exceptional / One Time Profit

 Exceptional item pertains to the Sale of portfolio of brands of the Company to Lupin Limited.-- Page 30 Annual Report

Very Small Equity capital 

 . Issued, Subscribed and Paid-up Share Capital - The issued, subscribed and paid-up share
capital of the Company as at 31st March, 2023 is ₹1,29,15,000/- (Rupees One Crore Twenty Nine
Lacs Fifteen Thousand Only) comprising of 12,91,500 equity shares of ₹ 10/- (Rupees Ten Only)
each -- Page  30 

Dividend 

a final dividend of Rs.20/- per equity share of face value of Rs.10/-
(Rupees Ten only) @ 200% for the financial year ended 31st March 2023-- Page 30

Blog Comments

 Some shares- shares Anglo French Drugs are available , for sale / purchase ,with  Dealers of Rare Indian Shares ( Please Recheck this )